Currently lacking, and which we begin to fulfill here, is a panel of different Smn inducible alleles that can be used in future experiments to address the cellular and temporal requirements of Smn induction in varying SMA disease severities. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.